Concepedia

Sangjae Kim

SK

5

Publications

180

Citations

5

H-Index

2001

Active since

Affiliations

GemVax & KAEL (South Korea)(Current)

Hanyang University

Seoul National University

Sangjae Kim is an author at GemVax & KAEL (South Korea) specializing in cell biology, medicine, and stem cells.

Top concepts

Publications per year

2001–2023

5

Publications

5

The novel vaccine peptide GV1001 effectively blocks β-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase

Hyun‐Hee Park, Kyu‐Yong Lee, Sangjae Kim et al. · Neurobiology of Aging · 2014 · 66 citations

, , +9

Neural stem cells injured by oxidative stress can be rejuvenated by GV1001, a novel peptide, through scavenging free radicals and enhancing survival signals

Hyun-Hee Park, Hyun-Jung Yu, Sangjae Kim et al. · NeuroToxicology · 2016 · 42 citations

, , +10

Robust Control of the Missile Attitude Based on Quaternion Feedback

Chanho Song, Sangjae Kim · IFAC Proceedings Volumes · 2001 · 36 citations

, , +6

Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial

Jung Hyun Jo, Yong‐Tae Kim, Ho Soon Choi et al. · British Journal of Cancer · 2023 · 22 citations · Full text

Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice

Shin Hye Kim, Gaon Jung, Sangjae Kim et al. · Frontiers in Cellular Neuroscience · 2018 · 14 citations · Full text

Rows per page

1–5 of 5